La Merie and PharmaPlus team up to provide No-Frills business intelligence solutions

New downloadable and searchable financial deal database PharmaPlus Financials provides extracts to evaluate and analyze licensing deals over the last ten years at affordable prices



BARCELONA, Spain and HUIZEN, The Netherlands | Mar 15, 2007 |
The Business Intelligence firm La Merie S.L. and the Dutch company PharmaPlus Consultancy BV announced today their collaboration to promote PharmaPlus’ proprietary financial deal database PharmaDeal Financials. The database is available in extracts for specific themes such as Diabetes & Obesity or Big Pharma & Big Biotech. PharmaDeal Financials extracts are unique searchable licensing deal databases. Available as online downloads, the databases contain financial deal specifics including deal size, upfront and milestone payments, royalties on sales, research funding and equity. The databases are fully searchable and provide quick access to financial deal specifics on one screen. PharmaDeal Financials databases allow easy comparison of deal structures with deal history from 1996 on. The products can be obtained on La Merie’s Online Store www.pipelinereview.com.

PharmaDeal Financials complements La Merie’s R&D Competitor Analysis series providing no-frills, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at affordable prices. The information is provided in a tabular format and fully referenced. Competitor projects are described by drug codes, target or mechanism of action, class of compound or product category, company, therapeutic area, indication, R&D stage and additional comments with a hyperlink leading to the source of information. The products of the R&D Competitor Analysis series are elaborated by independent analysts of La Merie Business Intelligence and distributed by PipelineReview.com.



About La Merie


La Merie S.L. is a Business Intelligence enterprise fully dedicated to provide high quality information on research and development to the biopharmaceutical industry. La Merie offers individual consultancy services and publishes reports and periodicals. PipelineReview.com is the News Center and Online Store of La Merie Business Intelligence. The company’s No-Frills Competitor Analysis series is published in R&D Pipeline News and is also available as individual reports on the site. For more information visit www.pipelinereview.com.


About PharmaPlus Consultancy

PharmaPlus Consultancy BV provides services on strategic alliances (licensing), initial market studies and project management for independent researches, universities and start-ups in the biotechnology and pharmaceutical field. Through the use of several internal proprietary databases, the company ensures the commercial exploitation of inventions originating from universities and
biopharmaceutical start-ups. For more information visit www.pharmaplus.nl


SOURCE: La Merie Business Intelligence

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top